Framingham Heart Study

This MedLibrary.org supplementary page on Framingham Heart Study is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:

The Framingham Heart Study is a cardiovascular study based in Framingham, Massachusetts. The study began in 1948 with 5,209 adult subjects from Framingham, and is now on its third generation of participants. Much of the now-common knowledge concerning heart disease, such as the effects of diet, exercise, and common medications such as aspirin, is based on this longitudinal study. It is a project of the National Heart, Lung, and Blood Institute, in collaboration with (since 1971) Boston University. Various health professionals from the hospitals and universities of Greater Boston staff the project.

Thomas Royle Dawber (1949-66) was appointed as chief epidemiologist shortly after the start of the project, when it was not progressing well.[1] The study had been intended to last 20 years, but at that time Dawber moved to Boston and became a preventive medicine chair, raising funds to continue the project and taking it with him.

One of the crucial questions in evidence-based medicine is how closely the people in a study resemble the patient you are dealing with.[2] Recently the Framingham studies have become regarded as overestimating risk, particularly in the lower risk groups, for UK populations.[3] There has been widespread discussion of the study, and it is generally accepted that the work is outstanding in its scope and duration, and is overall considered very useful. Researchers recently used contact information given by subjects over the last 30 years to map the social network of friends and family in the study.[4]

The initial population was 5,209 healthy men and women aged 30 to 60, not the whole of the town population, as is sometimes assumed. A similar longitudinal study has been carried out in a high proportion of the residents of Busselton, a town in Western Australia, over a period of many years;[5] however, Framingham is more widely cited.

Footnotes

  1. ^ Richmond (2006). "Obituary: Thomas Royle Dawber" (fee required). BMJ 332: 122. doi:10.1136/bmj.332.7533.122. 
  2. ^ David Hadden (7 September 2002). "Holidays in Framingham?". BMJ 325: 544. doi:10.1136/bmj.325.7363.544. 
  3. ^ Brindle P, Emberson J, Lampe F, et al (2003). "Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study". BMJ 327 (7426): 1267. doi:10.1136/bmj.327.7426.1267. PMID 14644971. 
  4. ^ Nicholas A. Christakis and James H. Fowler. (2007). "The Spread of Obesity in a Large Social Network Over 32 Years," New England Journal of Medicine 357 (4): 370-379
  5. ^ A list of publications from the Busselton study

References

  • Daniel Levy and Susan Brink. (2005). A Change of Heart: How the People of Framingham, Massachusetts, Helped Unravel the Mysteries of Cardiovascular Disease. Knopf. ISBN 0-375-41275-1.

External links

Wikipedia content modification information:

  • This page was last modified on 30 June 2008, at 10:58.

Wikipedia Authorship and Review

Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.

Wikipedia Usage Guidelines

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Framingham Heart Study".

The URL for this specific entry is:

All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.